Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer" What Is Good for the Surgeon Is Just as Good for the Patient?

[1]  J. Cameron,et al.  Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  M. Büchler,et al.  Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer , 2019, Annals of surgery.

[3]  M. Reni,et al.  Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma. , 2017 .

[4]  R. Grützmann,et al.  Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated , 2016, Annals of surgery.

[5]  M. Reni,et al.  Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.